SCHEMBL558962

SCHEMBL558962

COc1cccc(CCCCN)c1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA14 Q9ULX7 1/20 0.54
TAAR1 Q96RJ0 1/20 0.53
ABCB1 P08183 3/20 0.49
ALOX5 P09917 1/20 0.49
PTGS2 P35354 1/20 0.49
CHRM2 P08172 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
CYP1A2 P05177 1/20 0.44
GAA P10253 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
TSHR P16473 1/20 0.43
CRHBP P24387 1/20 0.43
MAPK1 P28482 1/20 0.43
CRHR2 Q13324 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629994 0.98 CA12 (0.52) CA12CA1CA2CA14TAAR1
SCHEMBL15610427 0.95 CA12 (0.55) CA12CA1CA2CA14TAAR1
SCHEMBL151944 0.87 TAAR1 (0.69) CA12CA1CA2CA14TAAR1
SCHEMBL30839502 0.87 TAAR1 (0.69) CA12CA1CA2CA14TAAR1
SCHEMBL1259539 0.84 ALOX5 (0.68) CA12CA1CA2CA14ABCB1
SCHEMBL7056767 0.84 TAAR1 (0.75) CA12CA1CA2CA14TAAR1
SCHEMBL9238920 0.83 ALOX5 (0.66) CA12CA1CA2CA14ABCB1
SCHEMBL15656477 0.83 ALOX5 (0.66) CA12CA1CA2CA14ABCB1
SCHEMBL9118416 0.83 ALOX5 (0.66) CA12CA1CA2CA14ABCB1
SCHEMBL15658926 0.83 ALOX5 (0.66) CA12CA1CA2CA14ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US disclosed
US-8232302-B2 Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-31 US disclosed
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2012-02-09 US disclosed
US-20110144123-A1 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-16 US disclosed
US-7846951-B2 Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-07 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
EP-2140865-A1 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters Vertex Pharmaceuticals Incorporated (US) 2010-01-06 EP disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed
EP-1682127-B1 THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2009-07-29 EP disclosed
US-20090018140-A1 THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2009-01-15 US disclosed
US-7407976-B2 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-05 US disclosed
EP-1682127-A1 THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2006-07-26 EP disclosed
US-20050148648-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-07-07 US disclosed
US-20050130970-A1 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-06-16 US disclosed
WO-2005049018-A1 THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148648-A1 Modulators of ATP-binding cassette transporters ABCB11, ABCB1, ABCC5 CA12 3938/4885CA1 4546/4885CA2 1582/4885
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 CA12 3938/4885CA1 4546/4885CA2 1582/4885
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters ABCB11, ABCB1, ABCC5 CA12 3938/4885CA1 4546/4885CA2 1582/4885
US-20090018140-A1 THIAZOLES AND OXAZOLES USEFUL AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 CA12 4708/4885CA1 4872/4885CA2 2694/4885
US-20050130970-A1 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters CFTR, ABCB1, ABCC2 CA12 4708/4885CA1 4872/4885CA2 2694/4885
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 CA12 3938/4885CA1 4546/4885CA2 1582/4885
US-20110144123-A1 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 CA12 4708/4885CA1 4872/4885CA2 2694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.